Report ID |
29459 |
Drug Identification Number |
02347393 |
Brand name |
MENVEO |
Common or Proper name |
Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM197 Conjugate Vaccine |
Company Name |
GLAXOSMITHKLINE INC |
Active Ingredient(s) |
MENINGOCOCCAL GROUP C OLIGOSACCHARIDE
CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN
MENINGOCOCCAL GROUP A OLIGOSACCHARIDE
MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE
MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE |
Strength(s) |
5MCG
47MCG
10MCG
5MCG
5MCG |
Dosage form(s) |
SOLUTION
POWDER FOR SOLUTION |
Route of administration |
INTRAMUSCULAR |
Packaging size |
1 dose |
ATC code |
J07AH |
ATC description |
BACTERIAL VACCINES |
Reason for shortage |
Delay in shipping of the drug. |
Anticipated start date |
|
Actual start date |
2017-12-06 |
Estimated end date |
2018-01-18 |
Actual end date |
2018-01-17 |
Shortage status |
Resolved |
Updated date |
2018-01-19 |
Company comments |
Menveo 5 dose format still available. Supply disruptions may be seen in the private market. |
Health Canada comments |
|
Company contact information |
1-800-387-7374 |